A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches

• Published in: International journal of molecular sciences 2015-11, Vol.16 (11), p.27561-27575
• Main Authors: Stiborová, Marie, Bárta, František, Levová, Kateřina, Hodek, Petr, Schmeiser, Heinz H, Arlt, Volker M, Martínek, Václav
• Format: Article
• Language: English
• Subjects: Acids; Activation, Metabolic; Animals; Aristolochic Acids - adverse effects; Aristolochic Acids - chemistry; Aristolochic Acids - metabolism; Catalysis; Catalytic Domain; Chemical reactions; contribution of cytochromes P450 in detoxification of aristolochic acid I in human and rat livers; Cytochrome; Cytochrome P-450 Enzyme Inhibitors - pharmacology; Cytochrome P-450 Enzyme System - chemistry; Cytochrome P-450 Enzyme System - metabolism; cytochrome P450-mediated detoxification of aristolochic acid I; Humans; Inactivation, Metabolic; Kidney Diseases - etiology; Kidney Diseases - metabolism; Liver; Liver - drug effects; Liver - metabolism; Male; Methylation - drug effects; Microsomes, Liver - drug effects; Microsomes, Liver - metabolism; Models, Molecular; Molecular Conformation; molecular modeling; Oxidation-Reduction - drug effects; plant nephrotoxin and carcinogen aristolochic acid I; Protein Binding; Rats; Rodents
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms161126047

Aristolochic acid I (AAI) is a plant alkaloid causing aristolochic acid nephropathy, Balkan endemic nephropathy and their associated urothelial malignancies. AAI is detoxified by cytochrome P450 (CYP)-mediated O-demethylation to 8-hydroxyaristolochic acid I (aristolochic acid Ia, AAIa). We previously investigated the efficiencies of human and rat CYPs in the presence of two other components of the mixed-functions-oxidase system, NADPH:CYP oxidoreductase and cytochrome b₅, to oxidize AAI. Human and rat CYP1A are the major enzymes oxidizing AAI. Other CYPs such as CYP2C, 3A4, 2D6, 2E1, and 1B1, also form AAIa, but with much lower efficiency than CYP1A. Based on velocities of AAIa formation by examined CYPs and their expression levels in human and rat livers, here we determined the contributions of individual CYPs to AAI oxidation in these organs. Human CYP1A2 followed by CYP2C9, 3A4 and 1A1 were the major enzymes contributing to AAI oxidation in human liver, while CYP2C and 1A were most important in rat liver. We employed flexible in silico docking methods to explain the differences in AAI oxidation in the liver by human CYP1A1, 1A2, 2C9, and 3A4, the enzymes that all O-demethylate AAI, but with different effectiveness. We found that the binding orientations of the methoxy group of AAI in binding centers of the CYP enzymes and the energies of AAI binding to the CYP active sites dictate the efficiency of AAI oxidation. Our results indicate that utilization of experimental and theoretical methods is an appropriate study design to examine the CYP-catalyzed reaction mechanisms of AAI oxidation and contributions of human hepatic CYPs to this metabolism.